Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Advancing Regulatory Science

Advancing Regulatory Science

                        Regulatory Science Extramural Research and Development Projects
          Advancing Regulatory Science News and Upcoming Events
          Centers of Excellence in Regulatory Science and Innovation (CERSIs)
          Past News and Events - Advancing Regulatory Science


                        Focus Areas of Regulatory Science Report Home
          Science & Research
          Science and Research Special Topics
          Advancing Regulatory Science
          READDI for the next pandemic - 11/09/2023Advancing Regulatory Science Webcast
    Event Title
              READDI for the next pandemic


                  November 9, 2023

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting InformationDate:
          
  


     
           

November 9, 2023

 





Research Triangle CERSI

Thursday, November 9th, 2023

Presented By

Picture of Nathaniel Moorman, Ph.D.
**Nathaniel Moorman, Ph.D.**
READDI co-founder and scientific adviser
Associate Professor in the UNC School of Medicine’s microbiology and immunology department

About the Presentation

In an era where the threat of pandemics looms large, READDI emerges as a beacon of hope and innovation. This presentation delved into the groundbreaking efforts of READDI, a leading non-profit drug company dedicated to developing small molecule antiviral drugs aimed at combating the viruses responsible for global pandemics. In this talk, we explored the cutting-edge research and development initiatives undertaken by READDI to create effective antiviral solutions. Focused exclusively on small molecules, these groundbreaking drugs represent a new frontier in the battle against viral outbreaks. This presentation provided a comprehensive overview of READDI’s innovative methodologies, from computational drug design and high-throughput screening to preclinical studies and clinical trials. Attendees gained insights into the potential impact of READDI, Inc.’s antiviral drugs on global public health. By targeting the viruses responsible for pandemics, these advancements have the potential to save lives, minimize economic disruptions, and bolster healthcare infrastructures worldwide. We also discussed the challenges faced in the process, emphasizing the importance of international collaboration and preparedness in the face of emerging viral threats.

About the Presenter

**Dr. Nathaniel Moorman** is READDI co-founder, scientific adviser, and associate professor in the UNC School of Medicine’s microbiology and immunology department. His research focuses on developing broad spectrum antiviral drugs that work against entire families of viruses that cause outbreaks, epidemics and pandemics. Dr. Moorman uses a combination of new technologies and traditional molecular virology techniques to investigate host-pathogen interactions. He leads multiple ongoing efforts to discover and develop novel direct-acting and host-targeted antiviral drugs for viruses of pandemic concern.

Dr. Moorman received a Bachelor of Science in microbiology from the University of Illinois Urbana-Champaign and his PhD from Washington University at St. Louis. He completed his postdoctoral training at Princeton University prior to joining the faculty at the University of North Carolina at Chapel Hill in 2010.


Recording

Play recording (58 mins)


For Questions:

Please contact Ruize Li at Ruize.Li@fda.hhs.gov.

                                                                                  Content current as of:
      11/20/2023More Meetings,
      Conferences, and
      Workshops
        
        Advancing Regulatory Science

          
                        Regulatory Science Extramural Research and Development Projects
          Advancing Regulatory Science News and Upcoming Events
          Centers of Excellence in Regulatory Science and Innovation (CERSIs)
          Past News and Events - Advancing Regulatory Science


                        Focus Areas of Regulatory Science Report
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop